Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Expert Review of Respiratory Medicine
|
June 8, 2010
Varenicline in smoking cessation
Serena Tonstad, Hans Rollema
Psychopharmacology
|
July 8, 2018
The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data
Hans Rollema, Raymond S Hurst
Pharmacology & Therapeutics
|
August 29, 2012
Nicotinic acetylcholine receptors: from basic science to therapeutics
Raymond Hurst, Hans Rollema, Daniel Bertrand
Clinical Therapeutics
|
August 30, 2021
A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline
Jeffrey Nau, David J Wyatt, Hans Rollema, et al.
Neuroscience and Biobehavioral Reviews
|
July 5, 2011
Smoking, quitting, and psychiatric disease: a review
Henri-Jean Aubin, Hans Rollema, Torgny H Svensson, et al.
Psychopharmacology
|
December 8, 2009
The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats
Eoin C O'Connor, Dale Parker, Hans Rollema, et al.
Pain
|
March 1, 1992
Do opioids evoke the release of serotonin in the spinal cord? An in vivo microdialysis study of the regulation of extracellular serotonin in the rat
Fátima F Matos, Hans Rollema, Jessica L Brown, et al.
European Journal of Pharmacology
|
January 3, 2007
Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex
Weldon E Horner, David E Johnson, Anne W Schmidt, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
January 11, 2014
Functional interactions of varenicline and nicotine with nAChR subtypes implicated in cardiovascular control
Hans Rollema, Cristina Russ, Theodore C Lee, et al.
Neuropharmacology
|
November 6, 2009
Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area
Christelle Reperant, Stéphanie Pons, Eric Dufour, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Expert Review of Respiratory Medicine
|
June 8, 2010
Varenicline in smoking cessation
Serena Tonstad, Hans Rollema
Psychopharmacology
|
July 8, 2018
The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data
Hans Rollema, Raymond S Hurst
Pharmacology & Therapeutics
|
August 29, 2012
Nicotinic acetylcholine receptors: from basic science to therapeutics
Raymond Hurst, Hans Rollema, Daniel Bertrand
Clinical Therapeutics
|
August 30, 2021
A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline
Jeffrey Nau, David J Wyatt, Hans Rollema, et al.
Neuroscience and Biobehavioral Reviews
|
July 5, 2011
Smoking, quitting, and psychiatric disease: a review
Henri-Jean Aubin, Hans Rollema, Torgny H Svensson, et al.
Psychopharmacology
|
December 8, 2009
The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats
Eoin C O'Connor, Dale Parker, Hans Rollema, et al.
Pain
|
March 1, 1992
Do opioids evoke the release of serotonin in the spinal cord? An in vivo microdialysis study of the regulation of extracellular serotonin in the rat
Fátima F Matos, Hans Rollema, Jessica L Brown, et al.
European Journal of Pharmacology
|
January 3, 2007
Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex
Weldon E Horner, David E Johnson, Anne W Schmidt, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
January 11, 2014
Functional interactions of varenicline and nicotine with nAChR subtypes implicated in cardiovascular control
Hans Rollema, Cristina Russ, Theodore C Lee, et al.
Neuropharmacology
|
November 6, 2009
Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area
Christelle Reperant, Stéphanie Pons, Eric Dufour, et al.
Page
of 4